BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Fascin 1 actin-bundling protein (FSCN1)

August 6, 2015 7:00 AM UTC

In vitro and mouse studies suggest inhibiting FSCN1 activity could help prevent or treat metastatic cancers. In an in vitro actin-bundling assay, high throughput screening identified a compound that i...